Inflammation is independent of steatosis in a murine model of steatohepatitis
Obesity and alcohol consumption synergistically promote steatohepatitis, and neutrophil infiltration is believed to be associated with steatosis. However, the underlying mechanisms remain obscure. Peroxisome proliferator–activated receptor gamma (PPARγ) plays a complex role in lipid metabolism and i...
Saved in:
Published in | Hepatology (Baltimore, Md.) Vol. 66; no. 1; pp. 108 - 123 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wolters Kluwer Health, Inc
01.07.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Obesity and alcohol consumption synergistically promote steatohepatitis, and neutrophil infiltration is believed to be associated with steatosis. However, the underlying mechanisms remain obscure. Peroxisome proliferator–activated receptor gamma (PPARγ) plays a complex role in lipid metabolism and inflammation; therefore, the purpose of this study was to dissect its role in regulating steatosis and neutrophil infiltration in a clinically relevant mouse steatohepatitis model of 3‐month high‐fat diet (HFD) feeding plus a binge of ethanol (HFD‐plus‐binge ethanol). Hepatocyte‐specific Pparg disruption reduced liver steatosis but surprisingly increased hepatic neutrophil infiltration after HFD‐plus‐binge ethanol. Knockout or knockdown of the PPARγ target gene, fat‐specific protein 27, reduced steatosis without affecting neutrophil infiltration in this model. Moreover, hepatocyte‐specific deletion of the Pparg gene, but not the fat‐specific protein 27 gene, markedly up‐regulated hepatic levels of the gene for chemokine (C‐X‐C motif) ligand 1 (Cxcl1, a chemokine for neutrophil infiltration) in HFD‐plus‐binge ethanol‐fed mice. In vitro, deletion of the Pparg gene also highly augmented palmitic acid or tumor necrosis factor alpha induction of Cxcl1 in mouse hepatocytes. In contrast, activation of PPARγ with a PPARγ agonist attenuated Cxcl1 expression in hepatocytes. Palmitic acid also up‐regulated interleukin‐8 (a key chemokine for human neutrophil recruitment) expression in human hepatocytes, which was attenuated and enhanced by cotreatment with a PPARγ agonist and antagonist, respectively. Finally, acute ethanol binge markedly attenuated HFD‐induced hepatic PPARγ activation, which contributed to the up‐regulation of hepatic Cxcl1 expression post–HFD‐plus‐binge ethanol. Conclusion: Hepatic PPARγ plays an opposing role in controlling steatosis and neutrophil infiltration, leading to dissociation between steatosis and inflammation; acute ethanol gavage attenuates hepatic PPARγ activation and subsequently up‐regulates hepatic CXCL1/interleukin‐8 expression, thereby exacerbating hepatic neutrophil infiltration. (Hepatology 2017;66:108–123). |
---|---|
AbstractList | Obesity and alcohol consumption synergistically promote steatohepatitis, and neutrophil infiltration is believed to be associated with steatosis. However, the underlying mechanisms remain obscure. Peroxisome proliferator-activated receptor gamma (PPARγ) plays a complex role in lipid metabolism and inflammation; therefore, the purpose of this study was to dissect its role in regulating steatosis and neutrophil infiltration in a clinically relevant mouse steatohepatitis model of 3-month high-fat diet (HFD) feeding plus a binge of ethanol (HFD-plus-binge ethanol). Hepatocyte-specific Pparg disruption reduced liver steatosis but surprisingly increased hepatic neutrophil infiltration after HFD-plus-binge ethanol. Knockout or knockdown of the PPARγ target gene, fat-specific protein 27, reduced steatosis without affecting neutrophil infiltration in this model. Moreover, hepatocyte-specific deletion of the Pparg gene, but not the fat-specific protein 27 gene, markedly up-regulated hepatic levels of the gene for chemokine (C-X-C motif) ligand 1 (Cxcl1, a chemokine for neutrophil infiltration) in HFD-plus-binge ethanol-fed mice. In vitro, deletion of the Pparg gene also highly augmented palmitic acid or tumor necrosis factor alpha induction of Cxcl1 in mouse hepatocytes. In contrast, activation of PPARγ with a PPARγ agonist attenuated Cxcl1 expression in hepatocytes. Palmitic acid also up-regulated interleukin-8 (a key chemokine for human neutrophil recruitment) expression in human hepatocytes, which was attenuated and enhanced by cotreatment with a PPARγ agonist and antagonist, respectively. Finally, acute ethanol binge markedly attenuated HFD-induced hepatic PPARγ activation, which contributed to the up-regulation of hepatic Cxcl1 expression post-HFD-plus-binge ethanol.
Hepatic PPARγ plays an opposing role in controlling steatosis and neutrophil infiltration, leading to dissociation between steatosis and inflammation; acute ethanol gavage attenuates hepatic PPARγ activation and subsequently up-regulates hepatic CXCL1/interleukin-8 expression, thereby exacerbating hepatic neutrophil infiltration. (Hepatology 2017;66:108-123). Obesity and alcohol consumption synergistically promote steatohepatitis, and neutrophil infiltration is believed to be associated with steatosis. However, the underlying mechanisms remain obscure. Peroxisome proliferator-activated receptor gamma (PPAR[gamma]) plays a complex role in lipid metabolism and inflammation; therefore, the purpose of this study was to dissect its role in regulating steatosis and neutrophil infiltration in a clinically relevant mouse steatohepatitis model of 3-month high-fat diet (HFD) feeding plus a binge of ethanol (HFD-plus-binge ethanol). Hepatocyte-specific Pparg disruption reduced liver steatosis but surprisingly increased hepatic neutrophil infiltration after HFD-plus-binge ethanol. Knockout or knockdown of the PPAR[gamma] target gene, fat-specific protein 27, reduced steatosis without affecting neutrophil infiltration in this model. Moreover, hepatocyte-specific deletion of the Pparg gene, but not the fat-specific protein 27 gene, markedly up-regulated hepatic levels of the gene for chemokine (C-X-C motif) ligand 1 (Cxcl1, a chemokine for neutrophil infiltration) in HFD-plus-binge ethanol-fed mice. In vitro, deletion of the Pparg gene also highly augmented palmitic acid or tumor necrosis factor alpha induction of Cxcl1 in mouse hepatocytes. In contrast, activation of PPAR[gamma] with a PPAR[gamma] agonist attenuated Cxcl1 expression in hepatocytes. Palmitic acid also up-regulated interleukin-8 (a key chemokine for human neutrophil recruitment) expression in human hepatocytes, which was attenuated and enhanced by cotreatment with a PPAR[gamma] agonist and antagonist, respectively. Finally, acute ethanol binge markedly attenuated HFD-induced hepatic PPAR[gamma] activation, which contributed to the up-regulation of hepatic Cxcl1 expression post-HFD-plus-binge ethanol. Conclusion: Hepatic PPAR[gamma] plays an opposing role in controlling steatosis and neutrophil infiltration, leading to dissociation between steatosis and inflammation; acute ethanol gavage attenuates hepatic PPAR[gamma] activation and subsequently up-regulates hepatic CXCL1/interleukin-8 expression, thereby exacerbating hepatic neutrophil infiltration. (Hepatology 2017;66:108-123). Obesity and alcohol consumption synergistically promote steatohepatitis, and neutrophil infiltration is believed to be associated with steatosis. However, the underlying mechanisms remain obscure. Peroxisome proliferator-activated receptor-gamma (PPARγ) plays a complex role in lipid metabolism and inflammation, therefore, the purpose of this study was to dissect its role in regulating steatosis and neutrophil infiltration in a clinically relevant mouse steatohepatitis model of 3-month high-fat diet (HFD) feeding plus a binge of ethanol (HFD - plus-binge ethanol). Hepatocyte-specific Pparg disruption reduced liver steatosis, but surprisingly increased hepatic neutrophil infiltration after HFD-plus-binge ethanol. Knockout or knockdown of the PPARγ target gene, fat-specific protein 27 ( Fsp27), reduced steatosis without affecting neutrophil infiltration in this model. Moreover, hepatocyte-specific deletion of the Pparg gene but not the Fsp27 gene markedly upregulated hepatic levels of Cxcl1 (a chemokine for neutrophil infiltration) in HFD-plus-binge ethanol-fed mice. In vitro, deletion of the Pparg gene also highly augmented palmitic acid or TNF-α induction of Cxcl1 in mouse hepatocytes. In contrast, activation of PPARγ with a PPARγ agonist attenuated Cxcl1 expression in hepatocytes. Palmitic acid also upregulated IL-8 (a key chemokine for human neutrophil recruitment) expression in human hepatocytes, which was attenuated and enhanced by co-treatment with a PPARγ agonist and antagonist, respectively. Finally, acute ethanol binge markedly attenuated HFD-induced hepatic PPARγ activation, which contributed to the upregulation of hepatic Cxcl1 expression post HFD-plus-bigne ethanol. In conclusion, hepatic PPARγ plays an opposing role in controlling steatosis and neutrophil infiltration, leading to dissociation between steatosis and inflammation. Acute ethanol gavage attenuates hepatic PPARγ activation and subsequently upregulates hepatic CXCL1/IL-8 expression, thereby exacerbating hepatic neutrophil infiltration. Obesity and alcohol consumption synergistically promote steatohepatitis, and neutrophil infiltration is believed to be associated with steatosis. However, the underlying mechanisms remain obscure. Peroxisome proliferator–activated receptor gamma (PPARγ) plays a complex role in lipid metabolism and inflammation; therefore, the purpose of this study was to dissect its role in regulating steatosis and neutrophil infiltration in a clinically relevant mouse steatohepatitis model of 3‐month high‐fat diet (HFD) feeding plus a binge of ethanol (HFD‐plus‐binge ethanol). Hepatocyte‐specific Pparg disruption reduced liver steatosis but surprisingly increased hepatic neutrophil infiltration after HFD‐plus‐binge ethanol. Knockout or knockdown of the PPARγ target gene, fat‐specific protein 27, reduced steatosis without affecting neutrophil infiltration in this model. Moreover, hepatocyte‐specific deletion of the Pparg gene, but not the fat‐specific protein 27 gene, markedly up‐regulated hepatic levels of the gene for chemokine (C‐X‐C motif) ligand 1 ( Cxcl1 , a chemokine for neutrophil infiltration) in HFD‐plus‐binge ethanol‐fed mice. In vitro, deletion of the Pparg gene also highly augmented palmitic acid or tumor necrosis factor alpha induction of Cxcl1 in mouse hepatocytes. In contrast, activation of PPARγ with a PPARγ agonist attenuated Cxcl1 expression in hepatocytes. Palmitic acid also up‐regulated interleukin‐8 (a key chemokine for human neutrophil recruitment) expression in human hepatocytes, which was attenuated and enhanced by cotreatment with a PPARγ agonist and antagonist, respectively. Finally, acute ethanol binge markedly attenuated HFD‐induced hepatic PPARγ activation, which contributed to the up‐regulation of hepatic Cxcl1 expression post–HFD‐plus‐binge ethanol. Conclusion : Hepatic PPARγ plays an opposing role in controlling steatosis and neutrophil infiltration, leading to dissociation between steatosis and inflammation; acute ethanol gavage attenuates hepatic PPARγ activation and subsequently up‐regulates hepatic CXCL1/interleukin‐8 expression, thereby exacerbating hepatic neutrophil infiltration. (H epatology 2017;66:108–123). Obesity and alcohol consumption synergistically promote steatohepatitis, and neutrophil infiltration is believed to be associated with steatosis. However, the underlying mechanisms remain obscure. Peroxisome proliferator–activated receptor gamma (PPARγ) plays a complex role in lipid metabolism and inflammation; therefore, the purpose of this study was to dissect its role in regulating steatosis and neutrophil infiltration in a clinically relevant mouse steatohepatitis model of 3‐month high‐fat diet (HFD) feeding plus a binge of ethanol (HFD‐plus‐binge ethanol). Hepatocyte‐specific Pparg disruption reduced liver steatosis but surprisingly increased hepatic neutrophil infiltration after HFD‐plus‐binge ethanol. Knockout or knockdown of the PPARγ target gene, fat‐specific protein 27, reduced steatosis without affecting neutrophil infiltration in this model. Moreover, hepatocyte‐specific deletion of the Pparg gene, but not the fat‐specific protein 27 gene, markedly up‐regulated hepatic levels of the gene for chemokine (C‐X‐C motif) ligand 1 (Cxcl1, a chemokine for neutrophil infiltration) in HFD‐plus‐binge ethanol‐fed mice. In vitro, deletion of the Pparg gene also highly augmented palmitic acid or tumor necrosis factor alpha induction of Cxcl1 in mouse hepatocytes. In contrast, activation of PPARγ with a PPARγ agonist attenuated Cxcl1 expression in hepatocytes. Palmitic acid also up‐regulated interleukin‐8 (a key chemokine for human neutrophil recruitment) expression in human hepatocytes, which was attenuated and enhanced by cotreatment with a PPARγ agonist and antagonist, respectively. Finally, acute ethanol binge markedly attenuated HFD‐induced hepatic PPARγ activation, which contributed to the up‐regulation of hepatic Cxcl1 expression post–HFD‐plus‐binge ethanol. Conclusion: Hepatic PPARγ plays an opposing role in controlling steatosis and neutrophil infiltration, leading to dissociation between steatosis and inflammation; acute ethanol gavage attenuates hepatic PPARγ activation and subsequently up‐regulates hepatic CXCL1/interleukin‐8 expression, thereby exacerbating hepatic neutrophil infiltration. (Hepatology 2017;66:108–123). |
Author | Zhou, Zhou Pacher, Pal Gonzalez, Frank J. Wang, Wei Cai, Yan Mukhopadhyay, Partha Zheng, Shusen Gao, Bin Xu, Ming‐Jiang Cao, Haixia |
AuthorAffiliation | 1 Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA 4 Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA 2 Department of Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China 3 Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA |
AuthorAffiliation_xml | – name: 1 Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA – name: 4 Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA – name: 2 Department of Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China – name: 3 Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA |
Author_xml | – sequence: 1 givenname: Wei surname: Wang fullname: Wang, Wei organization: Zhejiang University School of Medicine – sequence: 2 givenname: Ming‐Jiang surname: Xu fullname: Xu, Ming‐Jiang organization: National Institutes of Health – sequence: 3 givenname: Yan surname: Cai fullname: Cai, Yan organization: National Institutes of Health – sequence: 4 givenname: Zhou surname: Zhou fullname: Zhou, Zhou organization: National Institutes of Health – sequence: 5 givenname: Haixia surname: Cao fullname: Cao, Haixia organization: National Institutes of Health – sequence: 6 givenname: Partha orcidid: 0000-0002-1178-1274 surname: Mukhopadhyay fullname: Mukhopadhyay, Partha organization: National Institutes of Health – sequence: 7 givenname: Pal surname: Pacher fullname: Pacher, Pal organization: National Institutes of Health – sequence: 8 givenname: Shusen surname: Zheng fullname: Zheng, Shusen organization: Zhejiang University School of Medicine – sequence: 9 givenname: Frank J. surname: Gonzalez fullname: Gonzalez, Frank J. organization: National Institutes of Health – sequence: 10 givenname: Bin surname: Gao fullname: Gao, Bin email: bgao@mail.nih.gov organization: National Institutes of Health |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28220523$$D View this record in MEDLINE/PubMed |
BookMark | eNp1UbtOwzAUtVARfcDAD6BITAyh13ZM7AUJVQUqgWCA2XJjh7pK7BKnoP49pi1PwWIP53XvuX3Ucd4ZhA4xnGIAMpyZxSkRmIgd1MOM5CmlDDqoBySHVGAquqgfwhwAREb4HuoSTggwQnvoduLKStW1aq13iQ2JddosTHxcm_gyCa1RrQ9rIFFJvWysM0nttam-4Jgf9a0N-2i3VFUwB9t_gB4vxw-j6_Tm7moyurhJCwZCpJqeQSGM1qqkhGXElILlIEqqNXCVc5ZryAUt8TRuwxkH9i7jOdFQkGKq6QCdb3wXy2ltdBGHbVQlF42tVbOSXln5E3F2Jp_8i2QZx1lsZICOtwaNf16a0Mq5XzYuzixxLJJEGieRdfQ95tP_o75IGG4IReNDaEwpC9uuq4yptpIY5PuBZCxIrg8UFSe_FB-mf3G37q-2Mqv_ifJ6fL9RvAHZ95_E |
CitedBy_id | crossref_primary_10_1002_hep_31031 crossref_primary_10_1016_j_jcmgh_2018_12_009 crossref_primary_10_1096_fj_202000194R crossref_primary_10_1016_j_alcohol_2020_08_007 crossref_primary_10_1177_0192623318778508 crossref_primary_10_1136_gutjnl_2019_319720 crossref_primary_10_1038_nrgastro_2017_116 crossref_primary_10_1016_j_molimm_2022_10_011 crossref_primary_10_1002_hep_32756 crossref_primary_10_1007_s00018_022_04629_z crossref_primary_10_1016_j_jcmgh_2023_07_006 crossref_primary_10_1186_s12864_021_07784_y crossref_primary_10_1093_nutrit_nuab031 crossref_primary_10_1016_j_ebiom_2019_03_046 crossref_primary_10_1016_j_freeradbiomed_2025_03_021 crossref_primary_10_1016_j_phymed_2022_154599 crossref_primary_10_1016_j_jcmgh_2021_01_003 crossref_primary_10_3390_cells9071638 crossref_primary_10_3389_fphar_2023_1298341 crossref_primary_10_4254_wjh_v14_i7_1365 crossref_primary_10_1074_jbc_RA119_010233 crossref_primary_10_2174_0115680266295582240318060802 crossref_primary_10_1016_j_ajpath_2024_11_011 crossref_primary_10_1016_j_jcmgh_2018_01_003 crossref_primary_10_3892_etm_2021_10438 crossref_primary_10_1016_j_cyto_2020_155402 crossref_primary_10_3389_fphys_2021_782677 crossref_primary_10_1016_j_jcmgh_2024_04_009 crossref_primary_10_1038_s41388_019_0734_5 crossref_primary_10_1039_D0FO02653K crossref_primary_10_1016_j_dld_2019_12_008 crossref_primary_10_1194_jlr_M077941 crossref_primary_10_1016_j_bbagrm_2022_194802 crossref_primary_10_1007_s11356_021_15689_2 crossref_primary_10_1016_j_neubiorev_2018_05_002 crossref_primary_10_1016_j_comtox_2020_100147 crossref_primary_10_1152_ajpgi_00217_2019 crossref_primary_10_1016_j_toxlet_2021_06_018 crossref_primary_10_1155_2020_9735083 crossref_primary_10_1166_jbt_2022_3027 crossref_primary_10_1007_s12272_025_01537_1 crossref_primary_10_1016_j_jhep_2018_10_023 crossref_primary_10_1016_S0021_9258_17_49910_8 crossref_primary_10_1016_j_jnutbio_2017_11_011 crossref_primary_10_1136_gutjnl_2020_321767 crossref_primary_10_1016_j_biopha_2018_11_069 crossref_primary_10_1371_journal_pone_0195212 crossref_primary_10_1002_hep_30525 crossref_primary_10_3390_ijms23031062 crossref_primary_10_1016_j_alcohol_2020_04_004 crossref_primary_10_1016_j_ijbiomac_2022_03_148 crossref_primary_10_1016_j_atherosclerosis_2018_05_045 |
Cites_doi | 10.1016/j.metabol.2016.08.001 10.1002/hep.26419 10.1016/j.nut.2005.04.011 10.1002/9780470985571.ch16 10.1074/jbc.M210062200 10.1136/jim-2016-000204 10.1097/MEG.0b013e3283328b86 10.1002/hep.28960 10.1002/hep.27371 10.1111/j.1530-0277.2011.01472.x 10.1016/j.alcohol.2006.12.006 10.1002/hep.27332 10.1172/JCI200317223 10.1002/hep.20304 10.1053/j.gastro.2016.01.025 10.1056/NEJMoa060326 10.1097/01.ALC.0000134412.38510.F7 10.1038/cmi.2016.3 10.1016/S1542-3565(05)00743-3 10.1002/hep.27607 10.1016/j.cmet.2008.03.003 10.1002/hep.28000 10.1038/nm.3159 10.1016/j.jhep.2010.12.034 10.1053/j.gastro.2015.06.009 10.1096/fj.10-173716 10.1210/jc.2010-2129 10.1016/j.alcohol.2004.07.010 10.1016/j.bbrc.2005.08.070 10.1002/hep.23270 10.1053/j.gastro.2006.03.014 10.1002/hep.510250120 10.1002/hep.27921 10.1111/j.1365-2036.2009.04141.x 10.1146/annurev.med.53.082901.104018 10.7326/M15-1774 10.1093/ajcn/88.4.1097 10.1016/j.bbalip.2011.10.016 10.1002/hep.21752 10.1038/nature03988 10.1172/JCI88881 10.1053/j.gastro.2016.05.051 10.1016/j.dsx.2014.09.015 10.1111/acer.13049 10.1016/j.jhep.2013.06.023 10.1136/bmj.c1240 10.1002/hep.28823 10.1002/hep.21661 10.1074/jbc.M203436200 |
ContentType | Journal Article |
Copyright | 2017 by the American Association for the Study of Liver Diseases. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA. 2017 by the American Association for the Study of Liver Diseases. |
Copyright_xml | – notice: 2017 by the American Association for the Study of Liver Diseases. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA. – notice: 2017 by the American Association for the Study of Liver Diseases. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 H94 K9. 5PM |
DOI | 10.1002/hep.29129 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Nucleic Acids Abstracts |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1527-3350 |
EndPage | 123 |
ExternalDocumentID | PMC5481491 28220523 10_1002_hep_29129 HEP29129 |
Genre | article Journal Article Comparative Study Research Support, N.I.H., Intramural |
GrantInformation_xml | – fundername: National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health – fundername: Intramural NIH HHS grantid: Z01 AA000369 – fundername: Intramural NIH HHS grantid: ZIA AA000369 |
GroupedDBID | --- --K .3N .55 .GA .GJ .Y3 05W 0R~ 10A 186 1B1 1CY 1L6 1OB 1OC 1ZS 1~5 24P 31~ 33P 3O- 3SF 3WU 4.4 4G. 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AALRI AANHP AAONW AAQFI AAQQT AAQXK AASGY AAXRX AAXUO AAZKR ABCQN ABCUV ABEML ABIJN ABLJU ABMAC ABOCM ABPVW ABWVN ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACLDA ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADMUD ADNMO ADOZA ADXAS ADZMN ADZOD AECAP AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFFNX AFGKR AFPWT AFUWQ AFZJQ AHMBA AIACR AIURR AIWBW AJAOE AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD F00 F01 F04 F5P FD8 FDB FEDTE FGOYB FUBAC G-S G.N GNP GODZA H.X HBH HF~ HHY HHZ HVGLF HZ~ IHE IX1 J0M J5H JPC KBYEO KQQ LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 M65 MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ NNB NQ- O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K R2- RGB RIG RIWAO RJQFR ROL RPZ RWI RX1 RYL SEW SSZ SUPJJ TEORI UB1 V2E V9Y W2D W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXI X7M XG1 XV2 ZGI ZXP ZZTAW ~IA ~WT AAYXX ABJNI ACZKN AFNMH AGQPQ AHQVU CITATION MEWTI WXSBR AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 ADSXY H94 K9. 5PM |
ID | FETCH-LOGICAL-c5099-d360c9eddaf32542ef95709f3dd08a7857d0793f1b152858055099872d0c2cbd3 |
IEDL.DBID | DR2 |
ISSN | 0270-9139 |
IngestDate | Thu Aug 21 18:30:58 EDT 2025 Wed Aug 13 07:02:28 EDT 2025 Mon Jul 21 06:02:36 EDT 2025 Tue Jul 01 03:33:48 EDT 2025 Thu Apr 24 23:00:07 EDT 2025 Wed Jan 22 16:57:06 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2017 by the American Association for the Study of Liver Diseases. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5099-d360c9eddaf32542ef95709f3dd08a7857d0793f1b152858055099872d0c2cbd3 |
Notes | These authors contributed equally to this work. Supported by the intramural program of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health. Potential conflict of interest: Nothing to report. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 Wei Wang and Ming-Jiang Xu contribute equally to this work. |
ORCID | 0000-0002-1178-1274 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/5481491 |
PMID | 28220523 |
PQID | 1912248182 |
PQPubID | 996352 |
PageCount | 16 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5481491 proquest_journals_1912248182 pubmed_primary_28220523 crossref_citationtrail_10_1002_hep_29129 crossref_primary_10_1002_hep_29129 wiley_primary_10_1002_hep_29129_HEP29129 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2017 |
PublicationDateYYYYMMDD | 2017-07-01 |
PublicationDate_xml | – month: 07 year: 2017 text: July 2017 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Hepatology (Baltimore, Md.) |
PublicationTitleAlternate | Hepatology |
PublicationYear | 2017 |
Publisher | Wolters Kluwer Health, Inc |
Publisher_xml | – name: Wolters Kluwer Health, Inc |
References | 2004; 40 2002; 53 2015; 149 2004; 28 2017; 66 2012; 1821 2007; 286 1997; 25 2017; 65 2005; 336 2002; 277 2006; 130 2005; 437 2011; 96 2011; 55 2008; 7 2010; 340 2016; 165 2011; 35 2015; 9 2003; 278 2003; 111 2016; 13 2006; 355 2013; 19 2010; 22 2009; 30 2013; 59 2013; 58 2006; 40 2015; 62 2015; 61 2006; 22 2004; 34 2016; 64 2016; 40 2008; 88 2005; 3 2011; 25 2007; 46 2010; 51 2017; 127 2016; 151 2016; 150 (hep29129-bib-0044-20241017) 2006; 22 (hep29129-bib-0013-20241017) 2015; 62 (hep29129-bib-0040-20241017) 2013; 59 (hep29129-bib-0011-20241017) 2016; 64 (hep29129-bib-0001-20241017) 2010; 340 (hep29129-bib-0021-20241017) 2010; 51 (hep29129-bib-0032-20241017) 2015; 61 (hep29129-bib-0010-20241017) 2006; 40 (hep29129-bib-0023-20241017) 2003; 111 (hep29129-bib-0046-20241017) 2002; 277 (hep29129-bib-0007-20241017) 2009; 30 (hep29129-bib-0028-20241017) 2008; 7 (hep29129-bib-0034-20241017) 2013; 58 (hep29129-bib-0048-20241017) 2007; 286 (hep29129-bib-0024-20241017) 2011; 25 (hep29129-bib-0014-20241017) 2002; 53 (hep29129-bib-0043-20241017) 2004; 28 (hep29129-bib-0049-20241017) 2015; 62 (hep29129-bib-0008-20241017) 2011; 35 (hep29129-bib-0022-20241017) 2016; 165 (hep29129-bib-0025-20241017) 2016; 40 (hep29129-bib-0036-20241017) 2006; 130 (hep29129-bib-0027-20241017) 2015; 149 (hep29129-bib-0042-20241017) 2005; 336 (hep29129-bib-0029-20241017) 2003; 278 (hep29129-bib-0041-20241017) 2007; 46 (hep29129-bib-0035-20241017) 2006; 355 (hep29129-bib-0047-20241017) 2005; 437 (hep29129-bib-0016-20241017) 2013; 19 (hep29129-bib-0005-20241017) 2008; 88 (hep29129-bib-0037-20241017) 2015; 61 (hep29129-bib-0033-20241017) 2016; 150 (hep29129-bib-0002-20241017) 1997; 25 (hep29129-bib-0015-20241017) 2015; 9 (hep29129-bib-0026-20241017) 2011; 96 (hep29129-bib-0031-20241017) 2016; 64 (hep29129-bib-0003-20241017) 2005; 3 (hep29129-bib-0009-20241017) 2011; 55 (hep29129-bib-0017-20241017) 2017; 66 (hep29129-bib-0018-20241017) 2017; 65 (hep29129-bib-0038-20241017) 2017; 127 (hep29129-bib-0039-20241017) 2016; 13 (hep29129-bib-0019-20241017) 2012; 1821 (hep29129-bib-0030-20241017) 2015; 61 (hep29129-bib-0004-20241017) 2004; 34 (hep29129-bib-0045-20241017) 2004; 40 (hep29129-bib-0020-20241017) 2007; 46 (hep29129-bib-0006-20241017) 2010; 22 (hep29129-bib-0012-20241017) 2016; 151 |
References_xml | – volume: 53 start-page: 409 year: 2002 end-page: 435 article-title: The mechanisms of action of PPARs publication-title: Annu Rev Med – volume: 46 start-page: 823 year: 2007 end-page: 830 article-title: Palmitic acid induces production of proinflammatory cytokine interleukin‐8 from hepatocytes publication-title: Hepatology – volume: 1821 start-page: 809 year: 2012 end-page: 818 article-title: Roles of PPARs in NAFLD: potential therapeutic targets publication-title: Biochim Biophys Acta – volume: 40 start-page: 988 year: 2016 end-page: 999 article-title: Hepatic peroxisome proliferator–activated receptor gamma signaling contributes to alcohol‐induced hepatic steatosis and inflammation in mice publication-title: Alcohol Clin Exp Res – volume: 65 start-page: 1058 year: 2017 end-page: 1061 article-title: Pioglitazone for advanced fibrosis in NASH: new evidence, new challenges publication-title: Hepatology – volume: 111 start-page: 737 year: 2003 end-page: 747 article-title: Liver‐specific disruption of PPARgamma in leptin‐deficient mice improves fatty liver but aggravates diabetic phenotypes publication-title: J Clin Invest – volume: 22 start-page: 820 year: 2010 end-page: 825 article-title: A cohort study of the effect of alcohol consumption and obesity on serum liver enzyme levels publication-title: Eur J Gastroenterol Hepatol – volume: 40 start-page: 185 year: 2006 end-page: 191 article-title: Combined effects of high‐fat diet and ethanol induce oxidative stress in rat liver publication-title: Alcohol – volume: 149 start-page: 1030 year: 2015 end-page: 1041 article-title: Fat‐specific protein 27/CIDEC promotes development of alcoholic steatohepatitis in mice and humans publication-title: Gastroenterology – volume: 9 start-page: 46 year: 2015 end-page: 50 article-title: PPAR gamma gene—a review publication-title: Diabetes Metab Syndr – volume: 58 start-page: 1814 year: 2013 end-page: 1823 article-title: Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E‐selectin publication-title: Hepatology – volume: 278 start-page: 498 year: 2003 end-page: 505 article-title: Adipocyte‐specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator–activated receptor gamma1 (PPARgamma1) overexpression publication-title: J Biol Chem – volume: 151 start-page: 513 year: 2016 end-page: 525 article-title: Comparison of gene expression patterns between mouse models of nonalcoholic fatty liver disease and liver tissues from patients publication-title: Gastroenterology – volume: 46 start-page: 424 year: 2007 end-page: 429 article-title: The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis publication-title: Hepatology – volume: 437 start-page: 759 year: 2005 end-page: 763 article-title: A SUMOylation‐dependent pathway mediates transrepression of inflammatory response genes by PPAR‐gamma publication-title: Nature – volume: 165 start-page: 305 year: 2016 end-page: 315 article-title: Long‐term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial publication-title: Ann Intern Med – volume: 96 start-page: 1424 year: 2011 end-page: 1430 article-title: Up‐regulation of PPAR‐gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP‐1c induction publication-title: J Clin Endocrinol Metab – volume: 286 start-page: 183 year: 2007 end-page: 196 article-title: Anti‐inflammatory and antidiabetic roles of PPARgamma publication-title: Novartis Found Symp – volume: 340 start-page: c1240 year: 2010 article-title: Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies publication-title: BMJ – volume: 61 start-page: 1066 year: 2015 end-page: 1079 article-title: Hepatic inflammation and fibrosis: functional links and key pathways publication-title: Hepatology – volume: 40 start-page: 376 year: 2004 end-page: 385 article-title: Diverse regulation of NF‐kappaB and peroxisome proliferator–activated receptors in murine nonalcoholic fatty liver publication-title: Hepatology – volume: 7 start-page: 302 year: 2008 end-page: 311 article-title: Hepatic steatosis in leptin‐deficient mice is promoted by the PPARgamma target gene Fsp27 publication-title: Cell Metab – volume: 55 start-page: 673 year: 2011 end-page: 682 article-title: Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p‐AMPK publication-title: J Hepatol – volume: 30 start-page: 1137 year: 2009 end-page: 1149 article-title: Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study publication-title: Aliment Pharmacol Ther – volume: 355 start-page: 2297 year: 2006 end-page: 2307 article-title: A placebo‐controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis publication-title: N Engl J Med – volume: 130 start-page: 1636 year: 2006 end-page: 1642 article-title: Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta‐analysis of individual patient data publication-title: Gastroenterology – volume: 277 start-page: 34176 year: 2002 end-page: 34181 article-title: Constitutive activation of peroxisome proliferator–activated receptor‐gamma suppresses pro‐inflammatory adhesion molecules in human vascular endothelial cells publication-title: J Biol Chem – volume: 28 start-page: 139S year: 2004 end-page: 144S article-title: Pioglitazone prevents acute liver injury induced by ethanol and lipopolysaccharide through the suppression of tumor necrosis factor‐alpha publication-title: Alcohol Clin Exp Res – volume: 25 start-page: 108 year: 1997 end-page: 111 article-title: Excess weight risk factor for alcoholic liver disease publication-title: Hepatology – volume: 64 start-page: 1078 year: 2016 end-page: 1081 article-title: Alcohol and fat promote steatohepatitis: a critical role for fat‐specific protein 27/CIDEC publication-title: J Investig Med – volume: 35 start-page: 1361 year: 2011 end-page: 1367 article-title: A new model of interactive effects of alcohol and high‐fat diet on hepatic fibrosis publication-title: Alcohol Clin Exp Res – volume: 62 start-page: 1070 year: 2015 end-page: 1085 article-title: Short‐ or long‐term high‐fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1 publication-title: Hepatology – volume: 61 start-page: 857 year: 2015 end-page: 869 article-title: Transcriptional activation of Fsp27 by the liver‐enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis publication-title: Hepatology – volume: 64 start-page: 1398 year: 2016 end-page: 1400 article-title: Modeling fatty liver disease in animals: is there an optimal approach, and is the effort worthwhile? publication-title: Hepatology – volume: 25 start-page: 2538 year: 2011 end-page: 2550 article-title: Role for PPARgamma in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts publication-title: FASEB J – volume: 34 start-page: 81 year: 2004 end-page: 87 article-title: Obesity and alcoholic liver disease publication-title: Alcohol – volume: 61 start-page: 1227 year: 2015 end-page: 1238 article-title: CIDEC/FSP27 is regulated by peroxisome proliferator–activated receptor alpha and plays a critical role in fasting‐ and diet‐induced hepatosteatosis publication-title: Hepatology – volume: 88 start-page: 1097 year: 2008 end-page: 1103 article-title: Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index publication-title: Am J Clin Nutr – volume: 127 start-page: 55 year: 2017 end-page: 64 article-title: Liver inflammation and fibrosis publication-title: J Clin Invest – volume: 336 start-page: 215 year: 2005 end-page: 222 article-title: Increased expression of PPARgamma in high fat diet‐induced liver steatosis in mice publication-title: Biochem Biophys Res Commun – volume: 59 start-page: 1045 year: 2013 end-page: 1053 article-title: Cell‐specific PPARgamma deficiency establishes anti‐inflammatory and anti‐fibrogenic properties for this nuclear receptor in non‐parenchymal liver cells publication-title: J Hepatol – volume: 22 start-page: 60 year: 2006 end-page: 68 article-title: PPAR‐gamma response element activity in intact primary human adipocytes: effects of fatty acids publication-title: Nutrition – volume: 66 start-page: 64 year: 2017 end-page: 68 article-title: Nonalcoholic fatty liver disease: updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR‐gamma agonists publication-title: Metabolism – volume: 150 start-page: 1704 year: 2016 end-page: 1709 article-title: Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe? publication-title: Gastroenterology – volume: 13 start-page: 267 year: 2016 end-page: 276 article-title: Liver immunology and its role in inflammation and homeostasis publication-title: Cell Mol Immunol – volume: 62 start-page: 1551 year: 2015 end-page: 1562 article-title: Stimulation of nuclear receptor peroxisome proliferator–activated receptor‐gamma limits NF‐kappaB‐dependent inflammation in mouse cystic fibrosis biliary epithelium publication-title: Hepatology – volume: 51 start-page: 445 year: 2010 end-page: 453 article-title: Long‐term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the Fatty Liver Improvement by Rosiglitazone Therapy (FLIRT 2) extension trial publication-title: Hepatology – volume: 3 start-page: 1260 year: 2005 end-page: 1268 article-title: Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population publication-title: Clin Gastroenterol Hepatol – volume: 19 start-page: 557 year: 2013 end-page: 566 article-title: PPARgamma signaling and metabolism: the good, the bad and the future publication-title: Nat Med – volume: 66 start-page: 64 year: 2017 ident: hep29129-bib-0017-20241017 article-title: Nonalcoholic fatty liver disease: updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR‐gamma agonists publication-title: Metabolism doi: 10.1016/j.metabol.2016.08.001 – volume: 58 start-page: 1814 year: 2013 ident: hep29129-bib-0034-20241017 article-title: Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E‐selectin publication-title: Hepatology doi: 10.1002/hep.26419 – volume: 22 start-page: 60 year: 2006 ident: hep29129-bib-0044-20241017 article-title: PPAR‐gamma response element activity in intact primary human adipocytes: effects of fatty acids publication-title: Nutrition doi: 10.1016/j.nut.2005.04.011 – volume: 286 start-page: 183 year: 2007 ident: hep29129-bib-0048-20241017 article-title: Anti‐inflammatory and antidiabetic roles of PPARgamma publication-title: Novartis Found Symp doi: 10.1002/9780470985571.ch16 – volume: 278 start-page: 498 year: 2003 ident: hep29129-bib-0029-20241017 article-title: Adipocyte‐specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator–activated receptor gamma1 (PPARgamma1) overexpression publication-title: J Biol Chem doi: 10.1074/jbc.M210062200 – volume: 64 start-page: 1078 year: 2016 ident: hep29129-bib-0031-20241017 article-title: Alcohol and fat promote steatohepatitis: a critical role for fat‐specific protein 27/CIDEC publication-title: J Investig Med doi: 10.1136/jim-2016-000204 – volume: 22 start-page: 820 year: 2010 ident: hep29129-bib-0006-20241017 article-title: A cohort study of the effect of alcohol consumption and obesity on serum liver enzyme levels publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0b013e3283328b86 – volume: 65 start-page: 1058 year: 2017 ident: hep29129-bib-0018-20241017 article-title: Pioglitazone for advanced fibrosis in NASH: new evidence, new challenges publication-title: Hepatology doi: 10.1002/hep.28960 – volume: 61 start-page: 857 year: 2015 ident: hep29129-bib-0030-20241017 article-title: Transcriptional activation of Fsp27 by the liver‐enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis publication-title: Hepatology doi: 10.1002/hep.27371 – volume: 35 start-page: 1361 year: 2011 ident: hep29129-bib-0008-20241017 article-title: A new model of interactive effects of alcohol and high‐fat diet on hepatic fibrosis publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.2011.01472.x – volume: 40 start-page: 185 year: 2006 ident: hep29129-bib-0010-20241017 article-title: Combined effects of high‐fat diet and ethanol induce oxidative stress in rat liver publication-title: Alcohol doi: 10.1016/j.alcohol.2006.12.006 – volume: 61 start-page: 1066 year: 2015 ident: hep29129-bib-0037-20241017 article-title: Hepatic inflammation and fibrosis: functional links and key pathways publication-title: Hepatology doi: 10.1002/hep.27332 – volume: 111 start-page: 737 year: 2003 ident: hep29129-bib-0023-20241017 article-title: Liver‐specific disruption of PPARgamma in leptin‐deficient mice improves fatty liver but aggravates diabetic phenotypes publication-title: J Clin Invest doi: 10.1172/JCI200317223 – volume: 40 start-page: 376 year: 2004 ident: hep29129-bib-0045-20241017 article-title: Diverse regulation of NF‐kappaB and peroxisome proliferator–activated receptors in murine nonalcoholic fatty liver publication-title: Hepatology doi: 10.1002/hep.20304 – volume: 150 start-page: 1704 year: 2016 ident: hep29129-bib-0033-20241017 article-title: Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe? publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.01.025 – volume: 355 start-page: 2297 year: 2006 ident: hep29129-bib-0035-20241017 article-title: A placebo‐controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis publication-title: N Engl J Med doi: 10.1056/NEJMoa060326 – volume: 28 start-page: 139S year: 2004 ident: hep29129-bib-0043-20241017 article-title: Pioglitazone prevents acute liver injury induced by ethanol and lipopolysaccharide through the suppression of tumor necrosis factor‐alpha publication-title: Alcohol Clin Exp Res doi: 10.1097/01.ALC.0000134412.38510.F7 – volume: 13 start-page: 267 year: 2016 ident: hep29129-bib-0039-20241017 article-title: Liver immunology and its role in inflammation and homeostasis publication-title: Cell Mol Immunol doi: 10.1038/cmi.2016.3 – volume: 3 start-page: 1260 year: 2005 ident: hep29129-bib-0003-20241017 article-title: Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population publication-title: Clin Gastroenterol Hepatol doi: 10.1016/S1542-3565(05)00743-3 – volume: 61 start-page: 1227 year: 2015 ident: hep29129-bib-0032-20241017 article-title: CIDEC/FSP27 is regulated by peroxisome proliferator–activated receptor alpha and plays a critical role in fasting‐ and diet‐induced hepatosteatosis publication-title: Hepatology doi: 10.1002/hep.27607 – volume: 7 start-page: 302 year: 2008 ident: hep29129-bib-0028-20241017 article-title: Hepatic steatosis in leptin‐deficient mice is promoted by the PPARgamma target gene Fsp27 publication-title: Cell Metab doi: 10.1016/j.cmet.2008.03.003 – volume: 62 start-page: 1551 year: 2015 ident: hep29129-bib-0049-20241017 article-title: Stimulation of nuclear receptor peroxisome proliferator–activated receptor‐gamma limits NF‐kappaB‐dependent inflammation in mouse cystic fibrosis biliary epithelium publication-title: Hepatology doi: 10.1002/hep.28000 – volume: 19 start-page: 557 year: 2013 ident: hep29129-bib-0016-20241017 article-title: PPARgamma signaling and metabolism: the good, the bad and the future publication-title: Nat Med doi: 10.1038/nm.3159 – volume: 55 start-page: 673 year: 2011 ident: hep29129-bib-0009-20241017 article-title: Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p‐AMPK publication-title: J Hepatol doi: 10.1016/j.jhep.2010.12.034 – volume: 149 start-page: 1030 year: 2015 ident: hep29129-bib-0027-20241017 article-title: Fat‐specific protein 27/CIDEC promotes development of alcoholic steatohepatitis in mice and humans publication-title: Gastroenterology doi: 10.1053/j.gastro.2015.06.009 – volume: 25 start-page: 2538 year: 2011 ident: hep29129-bib-0024-20241017 article-title: Role for PPARgamma in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts publication-title: FASEB J doi: 10.1096/fj.10-173716 – volume: 96 start-page: 1424 year: 2011 ident: hep29129-bib-0026-20241017 article-title: Up‐regulation of PPAR‐gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP‐1c induction publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-2129 – volume: 34 start-page: 81 year: 2004 ident: hep29129-bib-0004-20241017 article-title: Obesity and alcoholic liver disease publication-title: Alcohol doi: 10.1016/j.alcohol.2004.07.010 – volume: 336 start-page: 215 year: 2005 ident: hep29129-bib-0042-20241017 article-title: Increased expression of PPARgamma in high fat diet‐induced liver steatosis in mice publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2005.08.070 – volume: 51 start-page: 445 year: 2010 ident: hep29129-bib-0021-20241017 article-title: Long‐term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the Fatty Liver Improvement by Rosiglitazone Therapy (FLIRT 2) extension trial publication-title: Hepatology doi: 10.1002/hep.23270 – volume: 130 start-page: 1636 year: 2006 ident: hep29129-bib-0036-20241017 article-title: Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta‐analysis of individual patient data publication-title: Gastroenterology doi: 10.1053/j.gastro.2006.03.014 – volume: 25 start-page: 108 year: 1997 ident: hep29129-bib-0002-20241017 article-title: Excess weight risk factor for alcoholic liver disease publication-title: Hepatology doi: 10.1002/hep.510250120 – volume: 62 start-page: 1070 year: 2015 ident: hep29129-bib-0013-20241017 article-title: Short‐ or long‐term high‐fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1 publication-title: Hepatology doi: 10.1002/hep.27921 – volume: 30 start-page: 1137 year: 2009 ident: hep29129-bib-0007-20241017 article-title: Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2009.04141.x – volume: 53 start-page: 409 year: 2002 ident: hep29129-bib-0014-20241017 article-title: The mechanisms of action of PPARs publication-title: Annu Rev Med doi: 10.1146/annurev.med.53.082901.104018 – volume: 165 start-page: 305 year: 2016 ident: hep29129-bib-0022-20241017 article-title: Long‐term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial publication-title: Ann Intern Med doi: 10.7326/M15-1774 – volume: 88 start-page: 1097 year: 2008 ident: hep29129-bib-0005-20241017 article-title: Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index publication-title: Am J Clin Nutr doi: 10.1093/ajcn/88.4.1097 – volume: 1821 start-page: 809 year: 2012 ident: hep29129-bib-0019-20241017 article-title: Roles of PPARs in NAFLD: potential therapeutic targets publication-title: Biochim Biophys Acta doi: 10.1016/j.bbalip.2011.10.016 – volume: 46 start-page: 823 year: 2007 ident: hep29129-bib-0041-20241017 article-title: Palmitic acid induces production of proinflammatory cytokine interleukin‐8 from hepatocytes publication-title: Hepatology doi: 10.1002/hep.21752 – volume: 437 start-page: 759 year: 2005 ident: hep29129-bib-0047-20241017 article-title: A SUMOylation‐dependent pathway mediates transrepression of inflammatory response genes by PPAR‐gamma publication-title: Nature doi: 10.1038/nature03988 – volume: 127 start-page: 55 year: 2017 ident: hep29129-bib-0038-20241017 article-title: Liver inflammation and fibrosis publication-title: J Clin Invest doi: 10.1172/JCI88881 – volume: 151 start-page: 513 year: 2016 ident: hep29129-bib-0012-20241017 article-title: Comparison of gene expression patterns between mouse models of nonalcoholic fatty liver disease and liver tissues from patients publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.05.051 – volume: 9 start-page: 46 year: 2015 ident: hep29129-bib-0015-20241017 article-title: PPAR gamma gene—a review publication-title: Diabetes Metab Syndr doi: 10.1016/j.dsx.2014.09.015 – volume: 40 start-page: 988 year: 2016 ident: hep29129-bib-0025-20241017 article-title: Hepatic peroxisome proliferator–activated receptor gamma signaling contributes to alcohol‐induced hepatic steatosis and inflammation in mice publication-title: Alcohol Clin Exp Res doi: 10.1111/acer.13049 – volume: 59 start-page: 1045 year: 2013 ident: hep29129-bib-0040-20241017 article-title: Cell‐specific PPARgamma deficiency establishes anti‐inflammatory and anti‐fibrogenic properties for this nuclear receptor in non‐parenchymal liver cells publication-title: J Hepatol doi: 10.1016/j.jhep.2013.06.023 – volume: 340 start-page: c1240 year: 2010 ident: hep29129-bib-0001-20241017 article-title: Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies publication-title: BMJ doi: 10.1136/bmj.c1240 – volume: 64 start-page: 1398 year: 2016 ident: hep29129-bib-0011-20241017 article-title: Modeling fatty liver disease in animals: is there an optimal approach, and is the effort worthwhile? publication-title: Hepatology doi: 10.1002/hep.28823 – volume: 46 start-page: 424 year: 2007 ident: hep29129-bib-0020-20241017 article-title: The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1002/hep.21661 – volume: 277 start-page: 34176 year: 2002 ident: hep29129-bib-0046-20241017 article-title: Constitutive activation of peroxisome proliferator–activated receptor‐gamma suppresses pro‐inflammatory adhesion molecules in human vascular endothelial cells publication-title: J Biol Chem doi: 10.1074/jbc.M203436200 |
SSID | ssj0009428 |
Score | 2.468072 |
Snippet | Obesity and alcohol consumption synergistically promote steatohepatitis, and neutrophil infiltration is believed to be associated with steatosis. However, the... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 108 |
SubjectTerms | Analysis of Variance Animal models Animals Binge Drinking - complications Binge Drinking - metabolism Biopsy, Needle Cell activation Cells, Cultured Chemokine CXCL1 - metabolism Chemokines Cytokines Diet, High-Fat Disease Models, Animal Ethanol Ethanol - administration & dosage Ethanol - adverse effects Fatty liver Fatty Liver - etiology Fatty Liver - metabolism Fatty Liver - pathology Gene deletion Hepatocytes Hepatocytes - cytology Hepatocytes - metabolism Hepatology High fat diet Immunohistochemistry Inflammation Inflammation - pathology Inflammation - physiopathology Interleukin 8 Lipid metabolism Liver Liver Function Tests Male Metastases Mice Mice, Inbred C57BL Mice, Knockout Neutrophils Obesity Palmitic acid Peroxisome proliferator-activated receptors PPAR gamma - metabolism Random Allocation Rodents Steatosis Tumor necrosis factor |
Title | Inflammation is independent of steatosis in a murine model of steatohepatitis |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep.29129 https://www.ncbi.nlm.nih.gov/pubmed/28220523 https://www.proquest.com/docview/1912248182 https://pubmed.ncbi.nlm.nih.gov/PMC5481491 |
Volume | 66 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB6tOCAulEdptwVkoR562cVxknUsTggtWpAWVVWROCBFdhyLFZBFTbjw6zvjPJblIVXcItlO7MzY8409_gbghxZ5FgVa4BQ32QDttRsoi16rkrgwSLS4xtKJ7vRiNLmMzq_iqx4ctXdhan6IbsONZoZfr2mCa1MeLkhDb_KHoVBornD9pVgtAkS_F9RRKvJ5VdHr4nS6rFpWIS4Ou5bLtugVwHwdJ_kcv3oDdPoJrtuu13Ent8PHygyzpxesjh8c2wasN8CUHdeatAm9vNiC1Wlz9L4N07PCofbUNx3ZrGSzLoFuxeaOkbZU89IXMM3uaRc_Zz7RzqIYv0jqOSs_w-Xp-M_JZNDkYhhkMZF42nDEM5Vbq12IPqXInYolVy60lidaJrG0RLXnAoOAIIkTHlOzRArLM5EZG-7ASjEv8q_AjDFhNNJccS0iF4y0szqUMghCg2qiVR9-tlJJs4aonPJl3KU1xbJIsbOp_z19OOiqPtTsHG9V2m1FmzYTtEzRTUXwgmhF9OFLLeXuDRRZS7vlfZBL8u8qECX3ckkxu_HU3Oj_ocsZ4BC8eN_vVDoZ__IP3_6_6ndYEwQqfLDwLqxUfx_zPYREldn3uv8PJnEH8w |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5tqdT2QsurXUqLhThw2cVxknUs9VIV0PJYVFUgcUGRHcdiRZtF3eyFX8-M89huAanqLZLtxM7MeB4efwOwq0WeRYEWKOIm66G-dj1l0WtVEjcGiRrXWDrRHZ0PhpfRyVV81YEvzV2YCh-iDbiRZPj9mgScAtL7c9TQm_yuLxTqqxfwkip6E3L-wY85eJSKfGVV9Ls4nS-rBleIi_126KI2emRiPs6U_NOC9Sro6C1cN5OvMk9u-7PS9LP7v3Ad_3d172C5tk3Z14qZVqCTF6vwalSfvq_B6LhwyEDVZUc2nrJxW0O3ZBPHiGHKydQ3MM1-USA_Z77WzrwZv0gcOp6uw-XR4cW3Ya8ux9DLYsLxtOGAZyq3VrsQ3UqROxVLrlxoLU-0TGJpCW3PBQZtgiROeEzDEiksz0RmbLgBS8WkyD8AM8aE0UBzxbWIXDDQzupQyiAIDXKKVl3Ya8iSZjVWOZXM-JlWKMsixcmm_vd0YaftelcBdDzVaauhbVrL6DRFTxXtFzRYRBfeV2Ru30DJtRQw74JcYIC2A6FyL7YU4xuPzo0uIHqdAS7B0_f5SaXDw-_-YfPfu27D6-HF6Cw9Oz4__QhvBNkYPnd4C5bK37P8E1pIpfnsBeEBlG4MDw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT-swEB6xSIjLY4c-Ngtx4NKSOItjcUJAVZYihEDigBTZcaxW8NLqNVz49YydpZRFQtwieZzYmRnPjD3-BmBf0DTxXUFRxWXSRHutm1xh1MoZLgwMLa5U5kS3ex127v2Lh-BhCo6quzAFPkS94WY0w67XRsGHSh-OQUN76bBFOZqraZj1Q4ebug2nt2PsKO7bwqoYdjnmeJlXsEIOPay7ThqjTx7m50TJ9w6stUDtBXisxl4knjy1XnLZSl4_wDr-cnKL8Kf0TMlxIUpLMJVmyzDXLc_eV6B7nmkUn-KqI-mPSL-uoJuTgSZGXPLByDYQQf6ZbfyU2Eo742b8opHP_mgV7ttndyedZlmMoZkEBsVTeaGT8FQpoT0MKmmqecAcrj2lnEiwKGDKYO1pV6JHEAWRE5huEaPKSWgilbcGM9kgSzeASCk9PxTIMkF97YZCK-Ex5rqeRDkRvAEHFVfipEQqNwUznuMCY5nGONjY_p4G7NWkwwKe4yuirYq1camhoxjjVPRe0F2hDVgvuFy_waTWmu3yBrAJ_tcEBpN7siXr9yw2NwaAGHO6OAXL3u8HFXfObuzD35-T7sLczWk7vjq_vtyEeWocDJs4vAUz-f-XdBvdo1zuWDV4A3AYCr4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inflammation+is+independent+of+steatosis+in+a+murine+model+of+steatohepatitis&rft.jtitle=Hepatology+%28Baltimore%2C+Md.%29&rft.au=Wang%2C+Wei&rft.au=Xu%2C+Ming%E2%80%90Jiang&rft.au=Cai%2C+Yan&rft.au=Zhou%2C+Zhou&rft.date=2017-07-01&rft.issn=0270-9139&rft.eissn=1527-3350&rft.volume=66&rft.issue=1&rft.spage=108&rft.epage=123&rft_id=info:doi/10.1002%2Fhep.29129&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_hep_29129 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-9139&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-9139&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-9139&client=summon |